国家卫生健康委:未面向企业开展入选基本药物目录培训

2021-04-03 国家卫生健康委 国家卫生健康委

3月15日,国家卫生健康委药政司发布《关于不存在面向企业入选基本药物目录开展培训和综合评价的声明》。

3月15日,国家卫生健康委药政司发布《关于不存在面向企业入选基本药物目录开展培训和综合评价的声明》。

近期,有机构以国家卫生健康委药政司参加,以及国家卫生健康委直属单位或协会名义面向医药企业举办入选基本药物目录培训班,开展基本药物目录中成药综合评价并收取评价项目费用。

《声明》指出,国家卫生健康委药政司不会委托、指导、支持相关机构和协会举办入选基本药物目录培训班,不会由企业申报品种开展基本药物目录中成药综合评价,并以此为由向企业收取费用。特提醒有关主体提高警惕,注重风险防范。国家卫生健康委全部内设机构、直属联系单位、业务主管社团组织、各专家委员会委员、主管报刊杂志等均可在国家卫生健康委网站查询到相关信息。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1770661, encodeId=97901e70661f4, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Wed Aug 04 10:43:30 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665485, encodeId=f2e8166548530, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Sun Jun 20 06:43:30 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456330, encodeId=4c3a1456330c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458093, encodeId=0467145809378, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493052, encodeId=2a831493052c9, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568173, encodeId=77e415681e346, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1770661, encodeId=97901e70661f4, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Wed Aug 04 10:43:30 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665485, encodeId=f2e8166548530, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Sun Jun 20 06:43:30 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456330, encodeId=4c3a1456330c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458093, encodeId=0467145809378, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493052, encodeId=2a831493052c9, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568173, encodeId=77e415681e346, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1770661, encodeId=97901e70661f4, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Wed Aug 04 10:43:30 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665485, encodeId=f2e8166548530, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Sun Jun 20 06:43:30 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456330, encodeId=4c3a1456330c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458093, encodeId=0467145809378, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493052, encodeId=2a831493052c9, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568173, encodeId=77e415681e346, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 hyf030
  4. [GetPortalCommentsPageByObjectIdResponse(id=1770661, encodeId=97901e70661f4, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Wed Aug 04 10:43:30 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665485, encodeId=f2e8166548530, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Sun Jun 20 06:43:30 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456330, encodeId=4c3a1456330c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458093, encodeId=0467145809378, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493052, encodeId=2a831493052c9, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568173, encodeId=77e415681e346, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1770661, encodeId=97901e70661f4, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Wed Aug 04 10:43:30 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665485, encodeId=f2e8166548530, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Sun Jun 20 06:43:30 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456330, encodeId=4c3a1456330c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458093, encodeId=0467145809378, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493052, encodeId=2a831493052c9, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568173, encodeId=77e415681e346, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1770661, encodeId=97901e70661f4, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Wed Aug 04 10:43:30 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665485, encodeId=f2e8166548530, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Sun Jun 20 06:43:30 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456330, encodeId=4c3a1456330c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458093, encodeId=0467145809378, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493052, encodeId=2a831493052c9, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568173, encodeId=77e415681e346, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon Apr 05 05:43:30 CST 2021, time=2021-04-05, status=1, ipAttribution=)]

相关资讯

陈竺:抗癌药等列入第二版基本药物目录

  ●医联体,是让基层医院真正强起来,和大医院上下联动、沟通、一体化的构架   ●第二版基本药物目录即将出台,药品品种、覆盖面扩大,抗癌药、心脑血管重症、血浆制品等列入   ●从“卫生经济学”角度选出医保覆盖的20个大病病种   ●这一次可能涉及卫生部门的机构改革,而且“面比较大,也比较深”   本报北京3月5日电 “我很荣幸,今天总理政府工作报告在附注中把儿童白血病等20种重大疾病列出来

国家基本药物目录增165种药品

前日日,国家卫健委发布将于11月1日起实施的《2018年版国家基本药物目录》。北京青年报记者注意到,新版目录中基本药物增加了165种,从原来的520种增加到685种。新增品种包括肿瘤用药12种、临床急需儿童用药22种等。今后目录将实行动态调整,调整周期原则上不超过3年。

国家卫健委调整基本药物目录,丙肝新药“丙通沙”将被纳入

近日,《关于完善国家基本药物制度的意见》通过国务院常务会议原则审议。9月5日召开的国办例行吹风会上,国家卫生健康委副主任曾益新介绍,国家卫健委同步启动了基本药物目录调整工作,“新增品种包括了抗肿瘤用药12种、临床急需儿童用药22种以及世界卫生组织推荐的全球首个也是国内唯一一个全口服、泛基因型、单一片剂的丙肝治疗新药”。记者了解到,该丙肝新药即于今年5月刚刚在国内获批上市的“吉三代”——丙通沙(索

基本药物目录调整在即 基层药师有话说

一纸《深化医药卫生体制改革2018年下半年重点工作任务》(国办发〔2018〕83号)红头文件的下发,再次引来了医药卫生各界的强烈反响。